Prospective Evaluation of the PleurX Catheter When Used to Treat Recurrent Ascites Associated with Malignancy

Angi Courtney*, Albert A Nemcek Jr, Stefanie Rosenberg, Sean Tutton, Michael Darcy, Greg Gordon

*Corresponding author for this work

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Purpose: To prospectively assess the safety of the PleurX catheter in the management of recurrent ascites in patients with advanced abdominal malignancy and the consequent quality of life among these patients. Materials and Methods: This was a multicenter, prospective study of PleurX catheters implanted between March 2004 and April 2005 for control of nonhepatic abdominal ascites associated with malignancy. A total of 34 subjects were included (age range, 40-81 years; mean age, 64.3 y) who underwent 440 drainage sessions. Subjects kept records of volume and frequency of ascites drainage and recorded any difficulties encountered with use of the device. Subjects assessed symptoms before device insertion and weekly for as long as 12 weeks. Serum laboratory values reflecting overall volume status were tracked. Results: All catheter insertions were successful without major procedural complications. Twenty-nine (85%) required no catheter intervention or separate therapeutic paracentesis during 12 weeks observation or until the patient's death. Three needed a total of 13 interventions to restore catheter function. Before 12 weeks, 26 subjects died. Five discontinued catheter use as a result of catheter function despite the presence of ascites. Ascites resolved in five patients. Bloating and abdominal discomfort were significantly reduced at 2 and 8 weeks (P < .05). At weekly follow-up, 83%-100% of subjects reported their ascites to be well controlled. There were no significant changes in blood chemistry results between baseline and 12 weeks. One case of peritonitis at 10 weeks resolved with antibiotic treatment. Conclusions: In terminally ill patients, PleurX catheter use resulted in improvement of ascites-related discomfort and was associated with low rates of serious adverse clinical events and catheter failure.

Original languageEnglish (US)
Pages (from-to)1723-1731
Number of pages9
JournalJournal of Vascular and Interventional Radiology
Volume19
Issue number12
DOIs
StatePublished - Dec 1 2008

Fingerprint

Ascites
Catheters
Neoplasms
Drainage
Paracentesis
Terminally Ill
Equipment and Supplies
Peritonitis
Multicenter Studies
Quality of Life
Observation
Prospective Studies
Anti-Bacterial Agents
Safety
Therapeutics
Serum

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Courtney, Angi ; Nemcek Jr, Albert A ; Rosenberg, Stefanie ; Tutton, Sean ; Darcy, Michael ; Gordon, Greg. / Prospective Evaluation of the PleurX Catheter When Used to Treat Recurrent Ascites Associated with Malignancy. In: Journal of Vascular and Interventional Radiology. 2008 ; Vol. 19, No. 12. pp. 1723-1731.
@article{015e902c9682437bac0f99057ca23c8a,
title = "Prospective Evaluation of the PleurX Catheter When Used to Treat Recurrent Ascites Associated with Malignancy",
abstract = "Purpose: To prospectively assess the safety of the PleurX catheter in the management of recurrent ascites in patients with advanced abdominal malignancy and the consequent quality of life among these patients. Materials and Methods: This was a multicenter, prospective study of PleurX catheters implanted between March 2004 and April 2005 for control of nonhepatic abdominal ascites associated with malignancy. A total of 34 subjects were included (age range, 40-81 years; mean age, 64.3 y) who underwent 440 drainage sessions. Subjects kept records of volume and frequency of ascites drainage and recorded any difficulties encountered with use of the device. Subjects assessed symptoms before device insertion and weekly for as long as 12 weeks. Serum laboratory values reflecting overall volume status were tracked. Results: All catheter insertions were successful without major procedural complications. Twenty-nine (85{\%}) required no catheter intervention or separate therapeutic paracentesis during 12 weeks observation or until the patient's death. Three needed a total of 13 interventions to restore catheter function. Before 12 weeks, 26 subjects died. Five discontinued catheter use as a result of catheter function despite the presence of ascites. Ascites resolved in five patients. Bloating and abdominal discomfort were significantly reduced at 2 and 8 weeks (P < .05). At weekly follow-up, 83{\%}-100{\%} of subjects reported their ascites to be well controlled. There were no significant changes in blood chemistry results between baseline and 12 weeks. One case of peritonitis at 10 weeks resolved with antibiotic treatment. Conclusions: In terminally ill patients, PleurX catheter use resulted in improvement of ascites-related discomfort and was associated with low rates of serious adverse clinical events and catheter failure.",
author = "Angi Courtney and {Nemcek Jr}, {Albert A} and Stefanie Rosenberg and Sean Tutton and Michael Darcy and Greg Gordon",
year = "2008",
month = "12",
day = "1",
doi = "10.1016/j.jvir.2008.09.002",
language = "English (US)",
volume = "19",
pages = "1723--1731",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "12",

}

Prospective Evaluation of the PleurX Catheter When Used to Treat Recurrent Ascites Associated with Malignancy. / Courtney, Angi; Nemcek Jr, Albert A; Rosenberg, Stefanie; Tutton, Sean; Darcy, Michael; Gordon, Greg.

In: Journal of Vascular and Interventional Radiology, Vol. 19, No. 12, 01.12.2008, p. 1723-1731.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prospective Evaluation of the PleurX Catheter When Used to Treat Recurrent Ascites Associated with Malignancy

AU - Courtney, Angi

AU - Nemcek Jr, Albert A

AU - Rosenberg, Stefanie

AU - Tutton, Sean

AU - Darcy, Michael

AU - Gordon, Greg

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Purpose: To prospectively assess the safety of the PleurX catheter in the management of recurrent ascites in patients with advanced abdominal malignancy and the consequent quality of life among these patients. Materials and Methods: This was a multicenter, prospective study of PleurX catheters implanted between March 2004 and April 2005 for control of nonhepatic abdominal ascites associated with malignancy. A total of 34 subjects were included (age range, 40-81 years; mean age, 64.3 y) who underwent 440 drainage sessions. Subjects kept records of volume and frequency of ascites drainage and recorded any difficulties encountered with use of the device. Subjects assessed symptoms before device insertion and weekly for as long as 12 weeks. Serum laboratory values reflecting overall volume status were tracked. Results: All catheter insertions were successful without major procedural complications. Twenty-nine (85%) required no catheter intervention or separate therapeutic paracentesis during 12 weeks observation or until the patient's death. Three needed a total of 13 interventions to restore catheter function. Before 12 weeks, 26 subjects died. Five discontinued catheter use as a result of catheter function despite the presence of ascites. Ascites resolved in five patients. Bloating and abdominal discomfort were significantly reduced at 2 and 8 weeks (P < .05). At weekly follow-up, 83%-100% of subjects reported their ascites to be well controlled. There were no significant changes in blood chemistry results between baseline and 12 weeks. One case of peritonitis at 10 weeks resolved with antibiotic treatment. Conclusions: In terminally ill patients, PleurX catheter use resulted in improvement of ascites-related discomfort and was associated with low rates of serious adverse clinical events and catheter failure.

AB - Purpose: To prospectively assess the safety of the PleurX catheter in the management of recurrent ascites in patients with advanced abdominal malignancy and the consequent quality of life among these patients. Materials and Methods: This was a multicenter, prospective study of PleurX catheters implanted between March 2004 and April 2005 for control of nonhepatic abdominal ascites associated with malignancy. A total of 34 subjects were included (age range, 40-81 years; mean age, 64.3 y) who underwent 440 drainage sessions. Subjects kept records of volume and frequency of ascites drainage and recorded any difficulties encountered with use of the device. Subjects assessed symptoms before device insertion and weekly for as long as 12 weeks. Serum laboratory values reflecting overall volume status were tracked. Results: All catheter insertions were successful without major procedural complications. Twenty-nine (85%) required no catheter intervention or separate therapeutic paracentesis during 12 weeks observation or until the patient's death. Three needed a total of 13 interventions to restore catheter function. Before 12 weeks, 26 subjects died. Five discontinued catheter use as a result of catheter function despite the presence of ascites. Ascites resolved in five patients. Bloating and abdominal discomfort were significantly reduced at 2 and 8 weeks (P < .05). At weekly follow-up, 83%-100% of subjects reported their ascites to be well controlled. There were no significant changes in blood chemistry results between baseline and 12 weeks. One case of peritonitis at 10 weeks resolved with antibiotic treatment. Conclusions: In terminally ill patients, PleurX catheter use resulted in improvement of ascites-related discomfort and was associated with low rates of serious adverse clinical events and catheter failure.

UR - http://www.scopus.com/inward/record.url?scp=56349161601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56349161601&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2008.09.002

DO - 10.1016/j.jvir.2008.09.002

M3 - Article

C2 - 18951041

AN - SCOPUS:56349161601

VL - 19

SP - 1723

EP - 1731

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 12

ER -